Efficacy And Safety Of Sofosbuvir/Velpatasvir Fixed Dose Combination With Ribavirin in Chronic HCV Infected Adults Who Participated in a Prior Gilead Sponsored HCV Treatment Study
Clinical trial NCT02300103 · COMPLETED
Trial details
- NCT number
- NCT02300103
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2016-07-02
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.